Application Nr Approved Date Route Status External Links
ANDA202523 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Nevirapine Is Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Adults And Pediatric Patients 15 Days And Older [See Clinical Studies (14.1 , 14.2) ]. Limitations Of Use: Based On Serious And Life-Threatening Hepatotoxicity Observed In Controlled And Uncontrolled Trials, Nevirapine Is Not Recommended To Be Initiated, Unless The Benefit Outweighs The Risk, In: • Adult Females With Cd4 + Cell Counts Greater Than 250 Cells/mm 3 Or • Adult Males With Cd4 + Cell Counts Greater Than 400 Cells/mm 3 [See Warnings And Precautions (5.1) ] . • Nevirapine Is An Nnrti Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Human Immunodeficiency Virus (Hiv-1) Infection In Adults And Pediatric Patients 15 Days And Older. ( 1 ) Limitations Of Use: Based On Serious And Life-Threatening Hepatotoxicity Observed In Controlled And Uncontrolled Trials, Nevirapine Is Not Recommended To Be Initiated, Unless The Benefit Outweighs The Risk, In: • Adult Females With Cd4 + Cell Counts Greater Than 250 Cells/mm 3 • Adult Males With Cd4 + Cell Counts Greater Than 400 Cells/mm 3 ( 1 , 5.1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nevirapine NEVIRAPINE ZINC4778

Comments